Priority Review Vouchers Revitalizing Neglected Disease Drug Development

Neglected tropical diseases (NTDs) impact more than one in six people worldwide, often the poorest, but are allocated less than 0.5 percent of global pharmaceutical investment. Yet, new approvals continue to be a trickle compared to what is happening elsewhere in drug development.